Staphylococci

被引：86

作者：

Casey, A. L.

Lambert, P. A.

Elliott, T. S. J. ^{[1
]}

机构：

[1] Univ Hosp Birmingham, NHS Fdn Trust, Queen Elizabeth Hosp, Dept Clin Microbiol & Infect Control, Birmingham B15 2TH, W Midlands, England

[2] Aston Univ, Dept Pharmaceut & Biol Sci, Birmingham B4 7ET, W Midlands, England

来源：

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2007年 / 29卷

关键词：

staphylococcus aureus; coagulase-negative staphylococci; antibiotics; antimicrobial resistance;

D O I：

10.1016/S0924-8579(07)72175-1

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Staphylococci are among the leading causes of nosocomial infections. Increasing insusceptibility to beta-lactams and the glycopeptides complicates treatment of these infections. This review examines the current status and future perspectives for the therapy of infections caused by Staphylococcus aureus and coagulase-negative staphylococci. (c) 2007 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

引用

页码：S23 / S32

页数：10

共 111 条

[1] The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus [J].

Appelbaum, PC .

CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 :16-23

[2] MRSA - the tip of the iceberg [J].

Appelbaum, PC .

CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 :3-10

[3] The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections [J].

Arbeit, RD ;

Maki, D ;

Tally, FP ;

Campanaro, E ;

Eisenstein, BI .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (12) :1673-1681

[4] A new UK strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-17) resistant to multiple antibiotics [J].

Aucken, HM ;

Ganner, M ;

Murchan, S ;

Cookson, BD ;

Johnson, AP .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (02) :171-175

[5] The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus [J].

Ayliffe, GAJ .

CLINICAL INFECTIOUS DISEASES, 1997, 24 :S74-S79

[6] Glycopeptide resistance in coagulase-negative staphylococci [J].

Biavasco, F ;

Vignaroli, C ;

Varaldo, PE .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (06) :403-417

[7] Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus [J].

Blot, SI ;

Vandewoude, KH ;

Hoste, EA ;

Colardyn, FA .

ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (19) :2229-2235

[8] Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin [J].

Bogdanovich, T ;

Ednie, LM ;

Shapiro, S ;

Appelbaum, PC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (10) :4210-4219

[9] Are the epidemiology and microbiology of methicillin-resistant Staphylococcus aureus changing? [J].

Boyce, JM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (08) :623-624

[10] Meticillin-resistant Staphylococcus aureus [J].

Boyce, JM ;

Cookson, B ;

Christiansen, K ;

Hori, S ;

Vuopio-Varkila, J ;

Kocagöz, S ;

Öztop, AY ;

Christiansen, K ;

Hori, S ;

Vuopio-Varkila, J ;

Kocagöz, S ;

Öztop, AY ;

Vandenbroucke-Grauls, CMJE ;

Harbarth, S ;

Pittet, D .

LANCET INFECTIOUS DISEASES, 2005, 5 (10) :653-663

← 1 2 3 4 5 6 7 8 9 10 →